Plain-English overview
SLU-PP-332 is not strictly a peptide, but it appears in adjacent performance and metabolic research because it targets exercise-like cellular pathways.
How it is thought to work
By activating estrogen-related receptors, it is studied for gene programs involved in mitochondrial biogenesis, fatty-acid oxidation and endurance adaptation.
Research interest areas
- Endurance models
- Fat oxidation
- Metabolic-health pathways
What the research suggests
The headline findings are preclinical, including endurance changes in animal models. Human safety and effectiveness are not established.